Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Three-dimensional modeling of and ligand docking to vitamin D receptor ligand binding domain.

Yamamoto K, Masuno H, Choi M, Nakashima K, Taga T, Ooizumi H, Umesono K, Sicinska W, VanHooke J, DeLuca HF, Yamada S.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1467-72.

2.
3.

Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model.

Yamada S, Yamamoto K, Masuno H, Choi M.

Steroids. 2001 Mar-May;66(3-5):177-87. Review.

PMID:
11179725
4.

Structure-function analysis of vitamin D and VDR model.

Yamada S, Yamamoto K, Masuno H.

Curr Pharm Des. 2000 May;6(7):733-48. Review.

PMID:
10828304
5.

Model of three-dimensional structure of vitamin D receptor and its binding mechanism with 1alpha,25-dihydroxyvitamin D(3).

Rotkiewicz P, Sicinska W, Kolinski A, DeLuca HF.

Proteins. 2001 Aug 15;44(3):188-99.

PMID:
11455592
6.

Ligand recognition by the vitamin D receptor.

Choi M, Yamamoto K, Masuno H, Nakashima K, Taga T, Yamada S.

Bioorg Med Chem. 2001 Jul;9(7):1721-30.

PMID:
11425573
7.
8.
9.

Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.

Mizwicki MT, Bishop JE, Norman AW.

Steroids. 2005 May-Jun;70(5-7):464-71.

PMID:
15862832
10.

Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.

Väisänen S, Peräkylä M, Kärkkäinen JI, Steinmeyer A, Carlberg C.

J Mol Biol. 2002 Jan 11;315(2):229-38.

PMID:
11779241
11.

Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis.

Choi M, Yamamoto K, Itoh T, Makishima M, Mangelsdorf DJ, Moras D, DeLuca HF, Yamada S.

Chem Biol. 2003 Mar;10(3):261-70.

12.

Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket.

Molnár F, Peräkylä M, Carlberg C.

J Biol Chem. 2006 Apr 14;281(15):10516-26.

13.

Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol.

Rochel N, Hourai S, Pérez-García X, Rumbo A, Mourino A, Moras D.

Arch Biochem Biophys. 2007 Apr 15;460(2):172-6.

PMID:
17346665
14.

Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.

Väisänen S, Peräkylä M, Kärkkäinen JI, Uskokovic MR, Carlberg C.

Mol Pharmacol. 2003 Jun;63(6):1230-7.

15.

Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3).

Norman AW, Adams D, Collins ED, Okamura WH, Fletterick RJ.

J Cell Biochem. 1999 Sep 1;74(3):323-33.

PMID:
10412035
16.

Gene regulatory potential of 1alpha,25-dihydroxyvitamin D(3) analogues with two side chains.

Bury Y, Herdick M, Uskokovic MR, Carlberg C.

J Cell Biochem Suppl. 2001;Suppl 36:179-90.

PMID:
11455583
17.

Role of residues 143 and 278 of the human nuclear Vitamin D receptor in the full-length and Delta165-215 deletion mutant.

Acevedo A, Stoynova L, Davis K, Solórzano R, Collins ED.

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):83-7.

PMID:
15225751
18.

Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.

Herdick M, Steinmeyer A, Carlberg C.

Chem Biol. 2000 Nov;7(11):885-94.

19.

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D.

Mol Cell. 2000 Jan;5(1):173-9.

Supplemental Content

Support Center